Advertisement

Topics

New Challenges that Redefine the Complexity of Commercialization

10:29 EDT 28 Jun 2017 | Drug Discovery Development

Part one of three in a series on bringing cell and gene therapies to market.
Contributed Author: 
Pete Belden, President of ICS, a unit of AmerisourseBergen
Topics: 

Original Article: New Challenges that Redefine the Complexity of Commercialization

NEXT ARTICLE

More From BioPortfolio on "New Challenges that Redefine the Complexity of Commercialization"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...